$IQV

Sherbet Eric sold $1.2M of IQV

Sherbet Eric (See Remarks) sold 5,000 shares of IQVIA HOLDINGS INC. (IQV) at $249.16 ($1.25M total) on 2026-07-29.

Original reporting
SEC EDGAR · Sherbet Eric
Published Jul 31, 2026, 9:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 9:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IQV
Neutral
medium confidence
Mentioned
$IQV
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IQVNeutralLow
01

Why it matters

Traders may monitor for follow-on insider activity, but this single sale does not change IQVIA’s fundamentals based on the provided text.

02

Market read

A disclosed insider sale of about $1.25M in IQVIA, with no accompanying company catalyst in the text.

03

What to watch

The filing does not state a 10b5-1 plan, but it also provides no reason for the sale, and insider transactions often have limited explanatory power without follow-on patterns or concurrent company news.

Relevance 6/10Novelty 3/10Timing: filed 2026-07-31, transaction dated 2026-07-29

Background

The article is an SEC Form 4 insider transaction disclosure for IQVIA Holdings Inc.

Company-level read

Ticker impact

$IQVNeutralMedium confidence
Context

IQVIA Form 4 shows officer Sherbet Eric sold 5,000 shares at $249.16 on 2026-07-29 for about $1.25M, leaving 20,999 shares.

Expected impact

Likely limited near-term impact; any reaction would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing is primary-source and time-stamped, but the transaction is small relative to company size and lacks accompanying company-specific news (no guidance, contract, or regulatory action). The absence of a stated 10b5-1 plan can raise interpretive noise, not a clear directional signal.

Market effects

No clear sector read-through; this is an issuer-specific insider transaction without operational or regulatory updates.

None indicated.

None indicated.

Counterpoint

The sale could reflect diversification or personal liquidity needs rather than negative expectations, especially since insider sales are common and not always predictive.

Key entities

  • IQVIA Holdings Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Sherbet Eric

    Officer who sold 5,000 shares in an open-market transaction.

Related articles

$IQVMed

5 Insightful Analyst Questions From IQVIA’s Q2 Earnings Call

IQVIA reported Q2 CY2026 results with revenue of $4.37B versus $4.30B estimates and adjusted EPS of $3.15 versus $3.03, with adjusted EBITDA of $994M. Management cited 6% organic growth and strong net new bookings. Full-year revenue guidance was lifted to $17.38B and adjusted EPS to $12.90. Analysts discussed bookings, outsourcing, AI, M&A, and margins.

Med

An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion

IQVIA Holdings CEO sold about $26.1 million of stock appreciation rights with a Feb 2027 expiration, while retaining a large share position, according to the filing and article. The company reported Q2 revenue up 8.7% to $4.37B, adjusted EPS up 12.1% to $3.15, and record clinical bookings of $3.15B, raising full-year guidance to $17.475B.

MedAI 8/10

IQVIA Holdings Inc. Q2 2026 Earnings Call Summary

IQVIA reported Q2 2026 results and said organic revenue growth accelerated to 6% YoY, driven by improving market conditions and execution. Management raised full-year 2026 guidance, citing 100 bps higher organic growth and more M&A contribution. It expects flat adjusted EBITDA margins around 23.2% and noted Charles River asset acquisition added 50 bps to M&A growth.

$IQVMedAI 8/10

IQVIA Holdings (IQV) Soars on Revenue Growth Outlook, Strong Q2

IQVIA Holdings (NYSE:IQV) rose after reporting strong Q2 results and raising its full-year revenue growth outlook. Q2 revenue grew 8.7% to $4.37B, while attributable net income fell 3.7% to $256M. FY26 revenue guidance increased to $17.275B-$17.475B, with adjusted EBITDA $4.0B-$4.05B and buybacks of $2.819B authorized.